Search Results - Hamberg, Paul
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
-
2
A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics by Lubberman, Floor J. E., Benoist, Guillemette E., Gerritsen, Winald, Burger, David M., Mehra, Niven, Hamberg, Paul, van Oort, Inge, van Erp, Nielka P.
Published 2019Text -
3
Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor by Hamberg, Paul, Woo, Margaret M., Chen, Lin-Chi, Verweij, Jaap, Porro, Maria Grazia, Zhao, Lily, Li, Wenkui, van der Biessen, Diane, Sharma, Sunil, Hengelage, Thomas, de Jonge, Maja
Published 2011Text -
4
The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial by Huijts, Charlotte M., Lougheed, Sinéad M., Bodalal, Zuhir, van Herpen, Carla M., Hamberg, Paul, Tascilar, Metin, Haanen, John B., Verheul, Henk M., de Gruijl, Tanja D., van der Vliet, Hans J.
Published 2019Text -
5
11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration by Snaterse, Gido, van Dessel, Lisanne F., van Riet, Job, Taylor, Angela E., van der Vlugt-Daane, Michelle, Hamberg, Paul, de Wit, Ronald, Visser, Jenny A., Arlt, Wiebke, Lolkema, Martijn P., Hofland, Johannes
Published 2021Text -
6
Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical Evidence by Kloth, Jacqueline S. L., Binkhorst, Lisette, de Wit, Annelieke S., de Bruijn, Peter, Hamberg, Paul, Lam, Mei H., Burger, Herman, Chaves, Ines, Wiemer, Erik A. C., van der Horst, Gijsbertus T. J., Mathijssen, Ron H. J.
Published 2015Text -
7
Prognostic factors in men with metastatic castration-resistant prostate cancer treated with cabazitaxel by Belderbos, Bodine P.S., de Wit, Ronald, Hoop, Esther Oomen-de, Nieuweboer, Annemieke, Hamberg, Paul, van Alphen, Robbert J., Bergman, André, van der Meer, Nelly, Bins, Sander, Mathijssen, Ron H.J., van Soest, Robert J.
Published 2017Text -
8
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma by Huijts, Charlotte M., Werter, Inge M., Lougheed, Sinéad M., Goedegebuure, Ruben S., van Herpen, Carla M., Hamberg, Paul, Tascilar, Metin, Haanen, John B., Verheul, Henk M., de Gruijl, Tanja D., van der Vliet, Hans J.
Published 2018Text -
9
Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor() by Beije, Nick, Onstenk, Wendy, Kraan, Jaco, Sieuwerts, Anieta M., Hamberg, Paul, Dirix, Luc Y., Brouwer, Anja, de Jongh, Felix E., Jager, Agnes, Seynaeve, Caroline M., Van, Ngoc M., Foekens, John A., Martens, John W.M., Sleijfer, Stefan
Published 2016Text -
10
Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer Patients by Bins, Sander, Huitema, Alwin D. R., Laven, Pim, Bouazzaoui, Samira el, Yu, Huixin, van Erp, Nielka, van Herpen, Carla, Hamberg, Paul, Gelderblom, Hans, Steeghs, Neeltje, Sleijfer, Stefan, van Schaik, Ron H. N., Mathijssen, Ron H. J., Koolen, Stijn L. W.
Published 2018Text -
11
Effects of prednisone on docetaxel pharmacokinetics in men with metastatic prostate cancer: A randomized drug–drug interaction study by Belderbos, Bodine P.S., Hussaarts, Koen G.A.M., van Harten, Leonie J., Oomen‐de Hoop, Esther, de Bruijn, Peter, Hamberg, Paul, van Alphen, Robbert J., Haberkorn, Brigitte C.M., Lolkema, Martijn P., de Wit, Ronald, van Soest, Robert J., Mathijssen, Ron H.J.
Published 2019Text -
12
The impact of a 1‐hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure by Krens, Stefanie D., Lubberman, Floor J. E., van Egmond, Marthe, Jansman, Frank G. A., Burger, David M., Hamberg, Paul, Vervenne, Walter L., Gelderblom, Hans, van der Graaf, Winette T. A., Desar, Ingrid M. E., van Herpen, Carla M. L., van Erp, Nielka P.
Published 2021Text -
13
A prospective observational registry evaluating clinical outcomes of Radium‐223 treatment in a nonstudy population by Badrising, Sushil K., Louhanepessy, Rebecca D., van der Noort, Vincent, Coenen, Jules L.L.M., Hamberg, Paul, Beeker, Aart, Wagenaar, Nils, Lam, Marnix G.E.H., Celik, Filiz, Loosveld, Olaf J.L., Oostdijk, Ad, Zuetenhorst, Hanneke, Haanen, John B., Vegt, Erik, Zwart, Wilbert, Bergman, Andries M.
Published 2020Text -
14
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients by Binkhorst, Lisette, Kloth, Jacqueline S. L., de Wit, Annelieke S., de Bruijn, Peter, Lam, Mei H., Chaves, Ines, Burger, Herman, van Alphen, Robbert J., Hamberg, Paul, van Schaik, Ron H. N., Jager, Agnes, Koch, Birgit C. P., Wiemer, Erik A. C., van Gelder, Teun, van der Horst, Gijsbertus T. J., Mathijssen, Ron H. J.
Published 2015Text -
15
Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients by Beije, Nick, Sieuwerts, Anieta M., Kraan, Jaco, Van, Ngoc M., Onstenk, Wendy, Vitale, Silvia R., van der Vlugt‐Daane, Michelle, Dirix, Luc Y., Brouwer, Anja, Hamberg, Paul, de Jongh, Felix E., Jager, Agnes, Seynaeve, Caroline M., Jansen, Maurice P. H. M., Foekens, John A., Martens, John W. M., Sleijfer, Stefan
Published 2017Text -
16
Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel by de Kruijff, Ingeborg E., Sieuwerts, Anieta M., Onstenk, Wendy, Kraan, Jaco, Smid, Marcel, Van, Mai N., van der Vlugt-Daane, Michelle, Oomen-de Hoop, Esther, Mathijssen, Ron H.J., Lolkema, Martijn P., de Wit, Ronald, Hamberg, Paul, Meulenbeld, Hielke J., Beeker, Aart, Creemers, Geert-Jan, Martens, John W.M., Sleijfer, Stefan
Published 2019Text -
17
RNA Biomarkers as a Response Measure for Survival in Patients with Metastatic Castration-Resistant Prostate Cancer by Boerrigter, Emmy, Benoist, Guillemette E., van Oort, Inge M., Verhaegh, Gerald W., de Haan, Anton F. J., van Hooij, Onno, Groen, Levi, Smit, Frank, Oving, Irma M., de Mol, Pieter, Smilde, Tineke J., Somford, Diederik M., Hamberg, Paul, Dezentjé, Vincent O., Mehra, Niven, van Erp, Nielka P., Schalken, Jack A.
Published 2021Text -
18
AR splice variants in circulating tumor cells of patients with castration‐resistant prostate cancer: relation with outcome to cabazitaxel by Sieuwerts, Anieta M., Onstenk, Wendy, Kraan, Jaco, Beaufort, Corine M., Van, Mai, De Laere, Bram, Dirix, Luc Y., Hamberg, Paul, Beeker, Aart, Meulenbeld, Hielke J., Creemers, Geert‐Jan, van Weerden, Wytske M., Jenster, Guido W., Nieuweboer, Annemieke J. M., Mathijssen, Ron H. J., de Wit, Ronald, Martens, John W. M., Sleijfer, Stefan
Published 2019Text -
19
An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients by Reijm, Esther A., Sieuwerts, Anieta M., Smid, Marcel, Vries, Joan Bolt-de, Mostert, Bianca, Onstenk, Wendy, Peeters, Dieter, Dirix, Luc Y., Seynaeve, Caroline M., Jager, Agnes, de Jongh, Felix E., Hamberg, Paul, van Galen, Anne, Kraan, Jaco, Jansen, Maurice P. H. M., Gratama, Jan W., Foekens, John A., Martens, John W. M., Berns, Els M. J. J., Sleijfer, Stefan
Published 2016Text -
20
The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact by van Dessel, Lisanne F., van Riet, Job, Smits, Minke, Zhu, Yanyun, Hamberg, Paul, van der Heijden, Michiel S., Bergman, Andries M., van Oort, Inge M., de Wit, Ronald, Voest, Emile E., Steeghs, Neeltje, Yamaguchi, Takafumi N., Livingstone, Julie, Boutros, Paul C., Martens, John W. M., Sleijfer, Stefan, Cuppen, Edwin, Zwart, Wilbert, van de Werken, Harmen J. G., Mehra, Niven, Lolkema, Martijn P.
Published 2019Text